MPATH-Dx Version 2.0 Simplifies Classification of Melanoma

FRIDAY, Jan. 13, 2023 (HealthDay News) -- The Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) has been revised to simplify diagnoses into four classes, according to a consensus statement published online Jan. 11 in JAMA Network Open.
Raymond L. Barnhill, M.D., from the Institut Curie in Paris, and colleagues revised the MPATH-Dx version 1.0 classification tool using feedback from dermatopathologists and members of the International Melanoma Pathology Study Group. All feedback was integrated into an updated and refined MPATH-Dx version 2.0.
The researchers note that in order to improve diagnostic concordance and provide more explicit guidance for treatment, the new MPATH-Dx version 2.0 schema simplifies the original five-class hierarchy into four classes. Histopathological criteria for classification of classes I and II lesions are clearly defined in the new version; specific provisions are made for the most frequently encountered low-cumulative sun damage pathway of melanoma progression and other less common pathways to melanoma; guidance is provided for classifying intermediate class II tumors versus melanoma; and a subset of pT1a melanomas with very low risk is recognized.
"We expect that the implementation of the new revised MPATH-Dx V2.0 schema into routine practice will provide a robust tool and adjunct for standardized diagnostic reporting of melanocytic lesions and management of patients to the benefit of both health care practitioners and patients," the authors write.
Several authors disclosed financial ties to the biotechnology and pharmaceutical industries.
Related Posts
Unos ‘compuestos permanentes’ podrían aumentar el riesgo de una complicación del embarazo
MARTES, 2 de noviembre de 2021 (HealthDay News) -- Los llamados "compuestos...
Niños en peligro: casi la mitad de los padres tienen medicamentos sobrantes en casa
LUNES, 24 de octubre de 2022 (HealthDay News) -- Tener acceso a los medicamentos...
AHA News: Summer Break Weight Gain Is Real, With Latino Children Especially at Risk
WEDNESDAY, July 12, 2023 (American Heart Association News) -- School's out for...
Un tratamiento para el cáncer de próstata podría aumentar los riesgos cardiacos
MIÉRCOLES, 27 de julio de 2022 (HealthDay News) -- La terapia hormonal es una...